Form D · Pharmaceuticals
THESAN PHARMACEUTICALS, INC.
Carlsbad, CA · CIK 0001557975
Offering snapshot reported Feb 24, 2014 · SEC filing
- Reported sold
- $17.4M Offering amount: $49.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 11, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 24, 2014 | Initial | $17,399,999 | No comparison | 5 | SEC filing |
| Sep 12, 2012 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212387
Source: Form D, filed Feb 24, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mette Agger | Director |
| Tiba Aynechi | Director |
| Peter Bisgaard | Director |
| Giovanni Ferrara | Director |
| John Gordon Foulkes | Director, Executive |
| Ed Monaghan | Executive |
| Michael Ross | Director |
| Henry Skinner | Director |
| Howard Welgus | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5864 Owens Avenue, Suite 200
Carlsbad, CA, 92008
Carlsbad, CA, 92008